Stroke Research

Stroke is classified as both a neurological and a cardiovascular disease, as it is a disruption in blood supply to the brain which causes the neurological abnormalities. There are two types of stroke; ischemic and hemorrhagic.

Stroke Research Products Targets

Products for Stroke Research - Page 41

Cat.No. Product Name Information/Activity
BCC6999 D-CPP-ene 117414-74-1
BCC6592 5,7-Dichlorokynurenic acid 131123-76-7
BCC7758 5,7-Dichlorokynurenic acid sodium salt 1184986-70-6
BCC6619 (±)-1-(1,2-Diphenylethyl)piperidine maleate 207461-99-2
BCC6205 DQP 1105 380560-89-4
BCC7280 Eliprodil Eliprodil(SL-820715) is a non-competitive NR2B-NMDA receptor antagonist(IC50=1 uM), less potent for NR2A- and NR2C-containing receptors(IC50> 100 uM).
BCC4904 Felbamate Felbamate (W-554) is a potent nonsedative anticonvulsant whose clinical effect may be related to the inhibition of N-methyl-D-aspartate (NMDA).
BCC7340 Gavestinel 153436-38-5
BCC6589 (S)-(-)-HA-966 111821-58-0
BCC5946 HU 211 Dexanabinol (HU-211) is an artificially synthesized cannabinoid derivative and lacks cannabimimetic effects. Dexanabinol exhibits not only the antioxidant and neuroprotective activities in brain but also anti-inflammatory activity by inhibiting NF-κB and decreasing cytokines such as TNFα and interleukin-6, which could ensure the integrity of BBB and reduce cell apoptosis and death. Dexanabinol is widely used in head injury or stroke treatment and has been shown to be safe in animals and humans.